New therapy could help stop age-related blindness
Age-related macular degeneration is the leading cause of legal blindness in New Zealand, but a now therapy being developed in Australia may offer sufferers some hope.
It will affect one in seven people over the age of 60 and has few warning signs. Joshua Chu-Tan is a researcher at Australian National University and has taken microRNA and injected it straight into the eye.
He joins Lynn to explain what his research discovered.